Containing methicillin-resistant S aureus. Surveillance, control, and treatment methods.

作者: Andrew E. Simor

DOI: 10.3810/PGM.2001.10.1043

关键词:

摘要: In the past two decades, prevalence of MRSA has increased in healthcare facilities many countries around world. The organism, which caused nosocomial outbreaks, also become endemic hospitals and long-term care facilities. Recently, reports community-acquired persons without known risk factors for organism have been increasing. Transmission occurs primarily from colonized or infected patients to others through hands personnel. infection may be life-threatening cause considerable morbidity, need prolonged hospitalization, costs. Treatment options are limited because organisms typically resistant multiple antibiotics, but newer agents being developed. However, there is reason concern about recent emergence glycopeptides, such as vancomycin. Efforts limit spread should include surveillance control measures, adequate hand hygiene appropriate contact isolation barrier precautions.

参考文章(21)
Maury Ellis Mulligan, Katherine A. Murray-Leisure, Bruce S. Ribner, Harold C. Standiford, Joseph F. John, Joyce A. Korvick, Carol A. Kauffman, Victor L. Yu, Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management The American Journal of Medicine. ,vol. 94, pp. 313- 328 ,(1993) , 10.1016/0002-9343(93)90063-U
Giuseppe Papia, Marie Louie, Arnold Tralla, Claudette Johnson, Veronica Collins, Andrew E. Simor, Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infection Control and Hospital Epidemiology. ,vol. 20, pp. 473- 477 ,(1999) , 10.1086/501655
Carine Chaix, Isabelle Durand-Zaleski, Corinne Alberti, Christian Brun-Buisson, Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA. ,vol. 282, pp. 1745- 1751 ,(1999) , 10.1001/JAMA.282.18.1745
J. Romero-Vivas, M. Rubio, C. Fernandez, J. J. Picazo, Mortality Associated with Nosocomial Bacteremia Due to Methicillin-Resistant Staphylococcus aureus Clinical Infectious Diseases. ,vol. 21, pp. 1417- 1423 ,(1995) , 10.1093/CLINIDS/21.6.1417
John A. Jernigan, Mark A. Clemence, Geraldine A. Stott, Maureen G. Titus, Carolyn H. Alexander, Carol M. Palumbo, Barry M. Farr, Control of Methicillin-Resistant Staphylococcus aureus at a University Hospital: One Decade Later Infection Control and Hospital Epidemiology. ,vol. 16, pp. 686- 696 ,(1995) , 10.2307/30141911
Suzanne F. Bradley, Methicillin-Resistant Staphylococcus aureus in Nursing Homes Drugs & Aging. ,vol. 10, pp. 185- 198 ,(1997) , 10.2165/00002512-199710030-00003
Tony Kim, Paul I. Oh, Andrew E. Simor, The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infection Control and Hospital Epidemiology. ,vol. 22, pp. 99- 104 ,(2001) , 10.1086/501871
Paul L Mulhausen, Lizzie J Harrell, Morris Weinberger, Gary G Kochersberger, John R Feussner, Contrasting methicillin-resistant Staphylococcus aureus colonization in veterans affairs and community nursing homes The American Journal of Medicine. ,vol. 100, pp. 24- 31 ,(1996) , 10.1016/S0002-9343(96)90007-8
Robert J. Rubin, Catherine A. Harrington, Anna Poon, Kimberly Dietrich, Jeremy A. Greene, Adil Moiduddin, The Economic Impact ofStaphylococcus aureusInfection in New York City Hospitals Emerging Infectious Diseases. ,vol. 5, pp. 9- 17 ,(1999) , 10.3201/EID0501.990102
A. Voss, D. Milatovic, C. Wallrauch-Schwarz, V. T. Rosdahl, I. Braveny, Methicillin-Resistant Staphylococcus aureus in Europe European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 13, pp. 50- 55 ,(1994) , 10.1007/BF02026127